Prevalence and outcomes of acute coronary syndrome patients with and without standard modifiable risk factors undergoing percutaneous coronary intervention

被引:0
|
作者
Ball, J. [1 ]
Dinh, D. [1 ]
Brennan, A. [1 ]
Ajani, A. [2 ]
Clark, D. [3 ]
Freeman, M. [4 ]
Oqueli, E. [5 ]
Hiew, C. [6 ]
Nanayakkara, S. [1 ]
Walton, T. [1 ]
Shaw, J. [7 ]
Chan, W. [7 ]
Reid, C. [1 ]
Stub, D. [1 ]
机构
[1] Monash Univ, Melbourne, Vic, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] Austin Hosp, Melbourne, Vic, Australia
[4] Box Hill Hosp, Melbourne, Vic, Australia
[5] Ballarat Hlth Serv, Ballarat, Vic, Australia
[6] Geelong Hosp, Geelong, Vic, Australia
[7] Nil, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Outcomes of patients with high bleeding risks characteristics presenting with acute coronary syndrome undergoing percutaneous coronary intervention
    Fu, A.
    Barry, Q.
    Boudreau, R.
    Clifford, C.
    Chow, A.
    Simard, T.
    Chong, A. Y.
    Dick, A.
    Froeschl, M.
    Glover, C.
    Hibbert, B.
    Labinaz, M.
    Le May, M.
    Russo, J.
    So, D.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1428 - 1428
  • [32] Prognostic value of serum glycated albumin in acute coronary syndrome patients without standard modifiable cardiovascular risk factors
    Zhang, Xiaoming
    Du, Yu
    Guo, Qianyun
    Ma, Xiaoteng
    Shi, Dongmei
    Zhou, Yujie
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [33] Blood Transfusion and the Risk of Acute Kidney Injury Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Karrowni, Wassef
    Vora, Amit Navin
    Dai, David
    Wojdyla, Daniel
    Dakik, Habib
    Rao, Sunil V.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (09)
  • [34] Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Norgard, Nicholas B.
    Abu-Fadel, Mazen
    VASCULAR HEALTH AND RISK MANAGEMENT, 2009, 5 : 873 - 882
  • [35] Antiplatelet Therapy for Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Fioretti, Vincenzo
    Sperandeo, Luca
    Gerardi, Donato
    Di Fazio, Aldo
    Stabile, Eugenio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [36] Safety and Effectiveness of Rivaroxaban in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention
    Li Xiaoyan
    Lu Ying
    Zhang Er Hong
    Zhang Ping
    Zhang Ping
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C150 - C150
  • [37] Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention
    Coughlan, J. J.
    Aytekin, Alp
    Ndrepepa, Gjin
    Schuepke, Stefanie
    Bernlochner, Isabell
    Mayer, Katharina
    Neumann, Franz Josef
    Menichelli, Maurizio
    Richardt, Gert
    Woehrle, Jochen
    Witzenbichler, Bernhard
    Gewalt, Senta
    Xhepa, Erion
    Kufner, Sebastian
    Sager, Hendrik B.
    Joner, Michael
    Ibrahim, Tareq
    Fusaro, Massimiliano
    Laugwitz, Karl Ludwig
    Schunkert, Heribert
    Kastrati, Adnan
    Cassese, Salvatore
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (07) : E010565
  • [38] Acute Kidney Injury Following Percutaneous Coronary Intervention for Acute Coronary Syndrome: Incidence, Aetiology, Risk Factors and Outcomes
    Carande, Elliott J.
    Brown, Karen
    Jackson, David
    Maskell, Nicholas
    Kouzaris, Loukas
    Greene, Giles
    Mikhail, Ashraf
    Obaid, Daniel R.
    ANGIOLOGY, 2022, 73 (02) : 139 - 145
  • [40] Effect of intracoronary tirofiban in patients undergoing percutaneous coronary intervention for acute coronary syndrome
    Wu, Tong-Guo
    Zhao, Oiang
    Huang, Wei-Guang
    Wei, Jian-Rui
    Chen, Si-Wei
    Zhao, Jin
    Huang, Li-Ping
    Wang, Le-Xin
    CIRCULATION JOURNAL, 2008, 72 (10) : 1605 - 1609